Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate. - DIAGO, M.; OLVEIRA, A.; SOLÁ, R.; ROMERO‐GÓMEZ, M.; MORENO‐OTERO, R.; PÉREZ, R.; SALMERÓN, J.; ENRÍQUEZ, J.; PLANAS, R.; GAVILÁN, J. C.; DEL OLMO, J.; URIBARRENA, R.; et al. (Alimentary Pharmacology & Therapeutics, 2007)